Esophageal erosion as a possible bacterial entry site in an acute lymphoblastic leukemia patient with sepsis

International Journal of Hematology

Volumn 77, Issue 4, 2003, Pages 395-398

  Ikegaya, Satoshi ^a   Yoshida, Akira ^a   Iwasaki, Hiromichi ^a   Naiki, Hironobu ^a   Ueda, Takanori ^a  

^a UNIVERSITY OF FUKUI   (Japan)

Author keywords

Enterococcus faecalis; Entry site; Esophageal erosion; Leukemia; Sepsis

Indexed keywords

AMPHOTERICIN B; ANTIINFECTIVE AGENT; CEFPIROME; CILASTATIN PLUS IMIPENEM; DOXORUBICIN; GRANULOCYTE COLONY STIMULATING FACTOR; IMIPENEM; IMMUNOGLOBULIN; ISEPAMICIN; ITRACONAZOLE; MEROPENEM; PREDNISOLONE; SPARFLOXACIN; SULPERAZON; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; AGED; ANTIBIOTIC THERAPY; ARTICLE; AUTOPSY; BACTERIUM ADHERENCE; BLOOD CULTURE; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CASE REPORT; CAUSE OF DEATH; CEREBROSPINAL FLUID CULTURE; CLINICAL FEATURE; ENTEROCOCCUS FAECALIS; ESOPHAGUS DISEASE; FEBRILE NEUTROPENIA; HERPES SIMPLEX VIRUS; HISTOPATHOLOGY; HUMAN; MALE; MENINGITIS; MICROCOCCUS; PATHOGENESIS; RESPIRATORY FAILURE; SEPSIS; SQUAMOUS EPITHELIUM; VIRUS INCLUSION;

EID: 0141457880     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02982651     Document Type: Article

References (9)

1. Balducci L, Haldrook JC, Morrison FS, et al. Acute leukemia and infections: perspectives from a general hospital. Am J Hematol. 1983;15:57-63.
2. Pennington JE. Fever neutropenia and malignancy: a clinical syndrome in evolution. Cancer. 1977;39:1345-1349.
3. Mori T, Sugita K, Suzuki T, et al. A novel monoclonal antibody, KOR-SA3544, which reacts to Philadelphia chromosome-positive acute lymphoblastic leukemia cells with high sensitivity. Leukemia. 1995;9:1233-1239.
4. Iwasaki H, Misaki H, Nakamura T, Ueda T. Surveillance of the serum Candida antigen titer for initiation of antifungal therapy after post-remission chemotherapy in patients with acute leukemia. Int J Hematol. 2000;71:266-272.
5. Hughes WT, Armstrong D, Bodey GP, et al. 1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America. Clin Infect Dis. 1997;25:551-573.
6. Becker K, Lubke HJ, Borchard F, Haussinger D. Inflammatory esophageal diseases caused by herpes simplex virus infections: overview and report of 15 personal cases. Z Gastroenterol. 1996;34:286-295.
7. Yokota T, Teshima H, Okajima Y, et al. Septicemia associated with hematopoietic disorders and its features according to respective primary disorders. Kansenshogaku Zasshi. 1996;70:108-115.
8. De Pauw BE, Donnelly JP. Infection in the immunocompromised host: general principles, In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Disease. 5th ed. Philadelphia: Churchill Livingstone; 2000:3079-3090.
9. Horiuchi A, Hasegawa H, Masaoka T, et al. Actual conditions of bacterial infection associated with hematopoietic disorders: changes in 10 years. Hanshin Study Group of Hematopoietic Disorders and Infections. Kansenshogaku Zasshi. 1990;64:299-309.